Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernardo Rocco

Showing results (11-20 of 355) with videos related to

Pageof 36
Sort By:
European Urology Focus|November 21, 2022
Re: Romain Diamand, Jean-Baptiste Roche, Elena Lievore, et al. External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol Focus. 2023;9:309-16Bernardo Rocco, Maria Chiara Sighinolfi
European Urology|February 19, 2020
Reply to Alessia Cimadamore, Marina Scarpelli, Liang Cheng, et al's Letter to the Editor, re: Maria Chiara Sighinolfi, Bernardo Rocco's Words of Wisdom re: EAU Guidelines: Prostate Cancer 2019. Mottet N, van den Bergh RCN, Briers E, et al. https://uroweb.org/guideline/prostate-Cancer/. Eur Urol 2019, 76:871Maria Chiara Sighinolfi, Bernardo Rocco
World Journal of Urology|March 18, 2019
Re: A systematic review of contemporary management of oligometastatic prostate cancer: fighting a challenge or tilting at windmills? From Slaoui et al., World J urol 2019. Long-term safety of local radiation therapy of newly diagnosed low burden metastatic prostate cancer: an unaddressed concernBernardo Rocco, Sighinolfi Maria Chiara
European Urology Oncology|May 22, 2025
Re: Matthew J. Roberts, Philip Cornford, Derya Tilki. Oncological Benefits of Extended Pelvic Lymph Node Dissection: More Fog or Clarity to the Debate? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.12.001Maria Chiara Sighinolfi, Bernardo Rocco
European Urology|September 8, 2023
Re: Freddie C. Hamdy, Jenny L. Donovan, J. Athene Lane, et al. Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med 2023; 388:1547-58Bernardo Rocco, Maria Chiara Sighinolfi
European Urology|September 26, 2022
Re: James W.F. Catto, Pramit Khetrapal, Federico Ricciardi, et al. Effect of Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients with Bladder Cancer: A Randomized Clinical Trial. JAMA 2022;327:2092-103Bernardo Rocco, Maria Chiara Sighinolfi
European Urology|July 28, 2019
Re: EAU Guidelines: Prostate Cancer 2019Maria Chiara Sighinolfi, Bernardo Rocco
European Urology|June 2, 2019
Re: Joaquin Mateo, Karim Fizazi, Silke Gillessen, et al. Managing Nonmetastatic Castration-resistant Prostate Cancer. Eur Urol 2019;75:285-93Bernardo Rocco, Maria Chiara Sighinolfi
European Urology|December 25, 2017
Re: Positron Emission Tomography/Computed Tomography-based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-resistant Prostate CancerBernardo Rocco, Ahmed Eissa, Giampaolo Bianchi
The Journal of Urology|March 11, 2005
Re: Is tumor volume an independent prognostic factor in clinically localized prostate cancer?Bernardo Rocco, Rodolfo Varela, Fabrizio Verweij
Pageof 36

Showing results (11-20 of 355) with videos related to

Sort By:
Pageof 36
European Urology Focus|November 21, 2022
Re: Romain Diamand, Jean-Baptiste Roche, Elena Lievore, et al. External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol Focus. 2023;9:309-16Bernardo Rocco, Maria Chiara Sighinolfi
European Urology|February 19, 2020
Reply to Alessia Cimadamore, Marina Scarpelli, Liang Cheng, et al's Letter to the Editor, re: Maria Chiara Sighinolfi, Bernardo Rocco's Words of Wisdom re: EAU Guidelines: Prostate Cancer 2019. Mottet N, van den Bergh RCN, Briers E, et al. https://uroweb.org/guideline/prostate-Cancer/. Eur Urol 2019, 76:871Maria Chiara Sighinolfi, Bernardo Rocco
World Journal of Urology|March 18, 2019
Re: A systematic review of contemporary management of oligometastatic prostate cancer: fighting a challenge or tilting at windmills? From Slaoui et al., World J urol 2019. Long-term safety of local radiation therapy of newly diagnosed low burden metastatic prostate cancer: an unaddressed concernBernardo Rocco, Sighinolfi Maria Chiara
European Urology Oncology|May 22, 2025
Re: Matthew J. Roberts, Philip Cornford, Derya Tilki. Oncological Benefits of Extended Pelvic Lymph Node Dissection: More Fog or Clarity to the Debate? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.12.001Maria Chiara Sighinolfi, Bernardo Rocco
European Urology|September 8, 2023
Re: Freddie C. Hamdy, Jenny L. Donovan, J. Athene Lane, et al. Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med 2023; 388:1547-58Bernardo Rocco, Maria Chiara Sighinolfi
European Urology|September 26, 2022
Re: James W.F. Catto, Pramit Khetrapal, Federico Ricciardi, et al. Effect of Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients with Bladder Cancer: A Randomized Clinical Trial. JAMA 2022;327:2092-103Bernardo Rocco, Maria Chiara Sighinolfi
European Urology|July 28, 2019
Re: EAU Guidelines: Prostate Cancer 2019Maria Chiara Sighinolfi, Bernardo Rocco
European Urology|June 2, 2019
Re: Joaquin Mateo, Karim Fizazi, Silke Gillessen, et al. Managing Nonmetastatic Castration-resistant Prostate Cancer. Eur Urol 2019;75:285-93Bernardo Rocco, Maria Chiara Sighinolfi
European Urology|December 25, 2017
Re: Positron Emission Tomography/Computed Tomography-based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-resistant Prostate CancerBernardo Rocco, Ahmed Eissa, Giampaolo Bianchi
The Journal of Urology|March 11, 2005
Re: Is tumor volume an independent prognostic factor in clinically localized prostate cancer?Bernardo Rocco, Rodolfo Varela, Fabrizio Verweij
Pageof 36